Baudax Bio Alpha and Beta Analysis
| BXRXDelisted Stock | USD 0.76 0.06 7.32% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Baudax Bio. It also helps investors analyze the systematic and unsystematic risks associated with investing in Baudax Bio over a specified time horizon. Remember, high Baudax Bio's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Baudax Bio's market risk premium analysis include:
Beta 1.92 | Alpha (0.59) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Baudax |
Baudax Bio Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Baudax Bio market risk premium is the additional return an investor will receive from holding Baudax Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Baudax Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Baudax Bio's performance over market.| α | -0.59 | β | 1.92 |
Baudax Bio Fundamentals Vs Peers
Comparing Baudax Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Baudax Bio's direct or indirect competition across all of the common fundamentals between Baudax Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Baudax Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Baudax Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Baudax Bio by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Baudax Bio to competition |
| Fundamentals | Baudax Bio | Peer Average |
| Return On Equity | -47.04 | -0.31 |
| Return On Asset | -1.15 | -0.14 |
| Operating Margin | (27.60) % | (5.51) % |
| Current Valuation | 17.72 M | 16.62 B |
| Shares Outstanding | 43.59 M | 571.82 M |
| Shares Owned By Insiders | 0.01 % | 10.09 % |
| Shares Owned By Institutions | 2.68 % | 39.21 % |
Baudax Bio Opportunities
Baudax Bio Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Baudax Bio Announces Closing of 4 Million Public Offering | 05/01/2023 |
2 | Baudax Bio Acquires TeraImmune, Inc. | 06/30/2023 |
About Baudax Bio Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Baudax or other delisted stocks. Alpha measures the amount that position in Baudax Bio has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Baudax Bio Upcoming Company Events
As portrayed in its financial statements, the presentation of Baudax Bio's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Baudax Bio's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Baudax Bio's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Baudax Bio. Please utilize our Beneish M Score to check the likelihood of Baudax Bio's management manipulating its earnings.
| 14th of November 2023 Upcoming Quarterly Report | View | |
| 22nd of February 2024 Next Financial Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of June 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Baudax Bio
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Baudax Stock
If you are still planning to invest in Baudax Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Baudax Bio's history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |